Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Association between Right Ventricular Contractile Function and Cardiac Events in Isolated Post-capillary and Combined Pre- and Post-capillary Pulmonary Hypertension.

Kusunose K, Yamada N, Yamada H, Nishio S, Saijo Y, Hirata Y, Torii Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

J Card Fail. 2019 Sep 2. pii: S1071-9164(19)30143-5. doi: 10.1016/j.cardfail.2019.08.021. [Epub ahead of print]

PMID:
31487533
2.

Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension.

Kusunose K, Yamada H, Nishio S, Hirata Y, Saijo Y, Torii Y, Yamada N, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30622-9. doi: 10.1016/j.jcmg.2019.07.002. [Epub ahead of print] No abstract available.

PMID:
31422131
3.

Updated Left Ventricular Diastolic Function Recommendations and Cardiovascular Events in Patients with Heart Failure Hospitalization.

Torii Y, Kusunose K, Yamada H, Nishio S, Hirata Y, Amano R, Yamao M, Zheng R, Saijo Y, Yamada N, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

J Am Soc Echocardiogr. 2019 Aug 1. pii: S0894-7317(19)30771-0. doi: 10.1016/j.echo.2019.06.006. [Epub ahead of print]

PMID:
31378421
4.

Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.

Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.

Sci Rep. 2019 Aug 1;9(1):11206. doi: 10.1038/s41598-019-47474-0.

5.

Lambda-like J wave due to acute myocardial infarction of the diagonal branch.

Yagi S, Ueno R, Sutou K, Wakatsuki T, Yamaguchi K, Saijo Y, Hara T, Ise T, Kusunose K, Bando M, Matsuura T, Tobiume T, Yamada H, Fukuda D, Soeki T, Akaike M, Sata M.

J Med Invest. 2019;66(1.2):185-187. doi: 10.2152/jmi.66.185.

6.

Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.

Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama JR, Lei XF, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M.

J Am Heart Assoc. 2019 Apr 2;8(7):e010860. doi: 10.1161/JAHA.118.010860.

7.

Left atrial functional response after a marathon in healthy amateur volunteers.

Hirata Y, Kusunose K, Yamada H, Morita S, Torii Y, Nishio S, Zheng R, Saijo Y, Fukuda D, Yagi S, Soeki T, Sata M.

Int J Cardiovasc Imaging. 2019 Apr;35(4):633-643. doi: 10.1007/s10554-018-1502-2. Epub 2018 Nov 23.

PMID:
30470971
8.

Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.

Nishimoto S, Aini K, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2018 Oct 16;5:144. doi: 10.3389/fcvm.2018.00144. eCollection 2018.

9.

Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure.

Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

Can J Cardiol. 2018 Oct;34(10):1307-1315. doi: 10.1016/j.cjca.2018.06.003. Epub 2018 Jun 7.

PMID:
30146462
10.

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M.

J Atheroscler Thromb. 2019 Mar 1;26(3):272-281. doi: 10.5551/jat.44735. Epub 2018 Aug 21.

11.

A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure.

Saijo Y, Yamada H, Kusunose K, Bando M, Nishio S, Torii Y, Hirata Y, Seno H, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Echocardiography. 2018 Oct;35(10):1587-1595. doi: 10.1111/echo.14098. Epub 2018 Jul 13.

PMID:
30005132
12.

Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.

Ganbaatar B, Fukuda D, Salim HM, Nishimoto S, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Sata M.

Atherosclerosis. 2018 Aug;275:124-132. doi: 10.1016/j.atherosclerosis.2018.05.053. Epub 2018 May 31.

PMID:
29902700
13.

Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.

Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2018 Aug 24;82(9):2253-2258. doi: 10.1253/circj.CJ-17-0758. Epub 2018 May 30.

14.

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M.

Circ J. 2018 Jun 25;82(7):1778-1787. doi: 10.1253/circj.CJ-18-0021. Epub 2018 May 25.

15.

Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients.

Kusunose K, Okushi Y, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ J. 2018 Jul 25;82(8):2103-2110. doi: 10.1253/circj.CJ-18-0017. Epub 2018 Apr 28.

16.

Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M.

Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.

PMID:
29700120
17.

Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score.

Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M.

Circ J. 2018 Apr 25;82(5):1369-1378. doi: 10.1253/circj.CJ-17-1289. Epub 2018 Mar 21.

18.

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.

Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M.

Eur J Pharmacol. 2018 Feb 5;820:222-228. doi: 10.1016/j.ejphar.2017.12.037. Epub 2017 Dec 18.

PMID:
29269019
19.

Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M.

Adv Ther. 2018 Jan;35(1):124-134. doi: 10.1007/s12325-017-0639-z. Epub 2017 Nov 28.

PMID:
29185199
20.

Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.

Yamazaki H, Yagi S, Torii Y, Amano R, Oomichi Y, Sangawa T, Fukuda D, Kadota M, Ise T, Ueno R, Hara T, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Akaike M, Sata M.

J Cardiol. 2018 Mar;71(3):305-309. doi: 10.1016/j.jjcc.2017.09.009. Epub 2017 Nov 1.

21.

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.

Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, Salim HM, Maimaituxun G, Nishio S, Takagawa Y, Hama S, Matsuura T, Yamaguchi K, Tobiume T, Soeki T, Wakatsuki T, Aihara KI, Akaike M, Shimabukuro M, Sata M.

Diabetol Metab Syndr. 2017 Oct 4;9:78. doi: 10.1186/s13098-017-0275-4. eCollection 2017.

22.

Preload Stress Echocardiography Predicts Outcomes in Patients With Preserved Ejection Fraction and Low-Gradient Aortic Stenosis.

Kusunose K, Yamada H, Nishio S, Torii Y, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. doi: 10.1161/CIRCIMAGING.117.006690.

PMID:
29021259
23.

Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.

Takagawa Y, Yagi S, Ise T, Ishii A, Nishikawa K, Fukuda D, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Katoh S, Aihara KI, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):746-751. doi: 10.1536/ihj.16-454. Epub 2017 Sep 30.

24.

Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome.

Yagi S, Soeki T, Aihara KI, Fukuda D, Ise T, Kadota M, Bando S, Matsuura T, Tobiume T, Yamaguchi K, Kusunose K, Yamada H, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):720-723. doi: 10.1536/ihj.16-278. Epub 2017 Sep 30.

25.

Echocardiographic Epicardial Adipose Tissue Thickness Is Associated with Symptomatic Coronary Vasospasm during Provocative Testing.

Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Shimabukuro M, Sata M.

J Am Soc Echocardiogr. 2017 Oct;30(10):1021-1027.e1. doi: 10.1016/j.echo.2017.06.024. Epub 2017 Aug 23.

PMID:
28843368
26.

Age-related changes in morphology of left atrial appendage in patients with atrial fibrillation.

Hirata Y, Kusunose K, Yamada H, Shimizu R, Torii Y, Nishio S, Saijo Y, Takao S, Soeki T, Sata M.

Int J Cardiovasc Imaging. 2018 Feb;34(2):321-328. doi: 10.1007/s10554-017-1232-x. Epub 2017 Aug 14.

PMID:
28808846
27.

RV Myocardial Strain During Pre-Load Augmentation Is Associated With Exercise Capacity in Patients With Chronic HF.

Kusunose K, Yamada H, Nishio S, Ishii A, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1240-1249. doi: 10.1016/j.jcmg.2017.03.022. Epub 2017 Jul 19.

28.

Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery.

Maimaituxun G, Shimabukuro M, Salim HM, Tabata M, Yuji D, Morimoto Y, Akasaka T, Matsuura T, Yagi S, Fukuda D, Yamada H, Soeki T, Sugimoto T, Tanaka M, Takanashi S, Sata M.

PLoS One. 2017 Jun 8;12(6):e0177170. doi: 10.1371/journal.pone.0177170. eCollection 2017.

29.

Plasma brain natriuretic peptide levels are elevated in patients with cancer.

Bando S, Soeki T, Matsuura T, Tobiume T, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Muguruma N, Takayama T, Kishimoto I, Kangawa K, Sata M.

PLoS One. 2017 Jun 1;12(6):e0178607. doi: 10.1371/journal.pone.0178607. eCollection 2017.

30.

Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).

Kusunose K, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Am J Cardiol. 2017 Jul 15;120(2):315-321. doi: 10.1016/j.amjcard.2017.04.024. Epub 2017 Apr 26.

PMID:
28532772
31.

Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.

Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M.

Vascul Pharmacol. 2017 Sep;96-98:19-25. doi: 10.1016/j.vph.2017.03.003. Epub 2017 Mar 27.

PMID:
28347868
32.

A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients.

Sai K, Kajinami K, Akao H, Iwadare M, Sato-Ishida R, Kawai Y, Takeda K, Tanimoto T, Yamano T, Akasaka T, Ishida T, Hirata KI, Saku K, Yagi S, Soeki T, Sata M, Ueno M, Miyazaki S, Shiraki A, Oyama JI, Node K, Sugamura K, Ogawa H, Kurose K, Maekawa K, Matsuzawa Y, Imatoh T, Hasegawa R; Japanese Pharmacogenomics Data Science Consortium, Saito Y.

Drug Metab Pharmacokinet. 2016 Dec;31(6):467-470. doi: 10.1016/j.dmpk.2016.09.002. Epub 2016 Sep 17.

PMID:
27839692
33.

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse.

Salim HM, Fukuda D, Yagi S, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2016 Oct 26;3:43. eCollection 2016.

34.

Purulent Pericarditis Accompanying Pericardial Abscess Induced by Nocardia in an Immunocompromised Patient.

Takashima A, Yagi S, Yamaguchi K, Watanabe S, Yamamoto N, Ito H, Kadota M, Hara T, Yamazaki H, Ise T, Kusunose K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Sata M.

Circ J. 2016 Oct 25;80(11):2409-2411. Epub 2016 Sep 15. No abstract available.

35.

Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation.

Takashima A, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Taketani Y, Shimabukuro M, Sata M.

Atherosclerosis. 2016 Nov;254:142-150. doi: 10.1016/j.atherosclerosis.2016.10.002. Epub 2016 Oct 5.

PMID:
27744130
36.

Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF.

Kusunose K, Torii Y, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Tobiume T, Yagi S, Soeki T, Wakatsuki T, Sata M.

JACC Cardiovasc Imaging. 2017 Feb;10(2):118-126. doi: 10.1016/j.jcmg.2016.03.019. Epub 2016 Sep 21.

37.

The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.

Shimabukuro M, Okawa C, Yamada H, Yanagi S, Uematsu E, Sugasawa N, Kurobe H, Hirata Y, Kim-Kaneyama JR, Lei XF, Takao S, Tanaka Y, Fukuda D, Yagi S, Soeki T, Kitagawa T, Masuzaki H, Sato M, Sata M.

J Nutr Biochem. 2016 Sep;35:66-73. doi: 10.1016/j.jnutbio.2016.05.010. Epub 2016 May 31.

PMID:
27416363
38.

Response Prediction and Influence of Tolvaptan in Chronic Heart Failure Patients Considering the Interaction of the Renin-Angiotensin-Aldosterone System and Arginine Vasopressin.

Kadota M, Ise T, Yagi S, Iwase T, Akaike M, Ueno R, Kawabata Y, Hara T, Ogasawara K, Bando M, Bando S, Matsuura T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Sata M.

Int Heart J. 2016 Jul 27;57(4):461-5. doi: 10.1536/ihj.15-491. Epub 2016 Jun 29.

39.

Depot- and gender-specific expression of NLRP3 inflammasome and toll-like receptors in adipose tissue of cancer patients.

Shimabukuro M, Sato H, Izaki H, Fukuda D, Uematsu E, Hirata Y, Yagi S, Soeki T, Sakaue H, Kanayama HO, Masuzaki H, Sata M.

Biofactors. 2016 Jul 8;42(4):397-406. doi: 10.1002/biof.1287. Epub 2016 Apr 18.

PMID:
27086574
40.

Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.

Nishimoto S, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Murata C, Kim-Kaneyama JR, Sato F, Bando M, Yagi S, Soeki T, Hayashi T, Imoto I, Sakaue H, Shimabukuro M, Sata M.

Sci Adv. 2016 Mar 25;2(3):e1501332. doi: 10.1126/sciadv.1501332. eCollection 2016 Mar.

41.

Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation.

Soeki T, Matsuura T, Bando S, Tobiume T, Uematsu E, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

J Cardiol. 2016 Dec;68(6):472-477. doi: 10.1016/j.jjcc.2015.12.007. Epub 2016 Mar 15.

42.

Inflammatory Biomarkers and Atherosclerosis.

Soeki T, Sata M.

Int Heart J. 2016;57(2):134-9. doi: 10.1536/ihj.15-346. Epub 2016 Mar 11. Review.

43.

Vegetation in the coronary sinus that concealed the presence of a coronary arteriovenous fistula in a patient with infectious endocarditis.

Takashima A, Yagi S, Yamaguchi K, Takagi E, Kanbara T, Ogawa H, Ise T, Kusunose K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Kitagawa T, Sata M.

Int J Cardiol. 2016 Mar 15;207:266-8. doi: 10.1016/j.ijcard.2016.01.057. Epub 2016 Jan 11. No abstract available.

PMID:
26808990
44.

Effects of the Addition of Eicosapentaenoic Acid to Strong Statin Therapy on Inflammatory Cytokines and Coronary Plaque Components Assessed by Integrated Backscatter Intravascular Ultrasound.

Niki T, Wakatsuki T, Yamaguchi K, Taketani Y, Oeduka H, Kusunose K, Ise T, Iwase T, Yamada H, Soeki T, Sata M.

Circ J. 2016;80(2):450-60. doi: 10.1253/circj.CJ-15-0813. Epub 2015 Dec 11.

45.

Erratum to: 'Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome'.

Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T, Nishimoto S, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Nutr J. 2015 Dec 1;14:121. doi: 10.1186/s12937-015-0112-2. No abstract available.

46.

[Case Report; Successful treatment with methotrexate and low-dose corticosteroids for recurrent cardiac sarcoidosis].

Ise T, Takagi E, Iwase T, Kusunose K, Yamaguchi K, Yagi S, Yamada H, Soeki T, Wakatsuki T, Sata M.

Nihon Naika Gakkai Zasshi. 2015 Jun 10;104(6):1175-9. Japanese. No abstract available.

PMID:
26571765
47.

Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome.

Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T, Nishimoto S, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Nutr J. 2015 Oct 29;14:111. doi: 10.1186/s12937-015-0102-4. Erratum in: Nutr J. 2015;14:121.

48.

Corrigendum: augmentation index does not reflect risk of coronary artery disease in elderly patients.

Hayashi S, Yamada H, Bando M, Hotchi J, Ise T, Yamaguchi K, Iwase T, Soeki T, Wakatsuki T, Tamaki T, Sata M.

Circ J. 2015;79(11):2521. doi: 10.1253/circj.CJ-66-0120. No abstract available.

49.

Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara K, Akaike M, Fukuda D, Salim HM, Ishida M, Matsuura T, Ise T, Yamaguchi K, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Matsumoto T, Sata M.

Diabetes Metab J. 2015 Aug;39(4):342-7. doi: 10.4093/dmj.2015.39.4.342. Epub 2015 Jul 21.

50.

Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis.

Bando S, Fukuda D, Soeki T, Nishimoto S, Uematsu E, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Atherosclerosis. 2015 Oct;242(2):407-14. doi: 10.1016/j.atherosclerosis.2015.07.043. Epub 2015 Jul 29.

PMID:
26282945

Supplemental Content

Support Center